Capstone Investment Advisors’s Clorox CLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $220K | Buy |
2,300
+100
| +5% | +$9.6K | ﹤0.01% | 1580 |
|
|
2026
Q1 | $228K | Buy |
+2,200
| New | +$249K | ﹤0.01% | 1484 |
|
|
2025
Q2 | – | Sell |
-9,200
| Closed | -$1.35M | – | 1610 |
|
|
2025
Q1 | $1.35M | Sell |
9,200
-14,400
| -61% | -$2.2M | ﹤0.01% | 792 |
|
|
2024
Q4 | $3.83M | Buy |
23,600
+1,600
| +7% | +$262K | 0.01% | 635 |
|
|
2024
Q3 | $3.58M | Buy |
22,000
+1,200
| +6% | +$178K | 0.01% | 558 |
|
|
2024
Q2 | $2.84M | Buy |
20,800
+4,500
| +28% | +$625K | 0.01% | 615 |
|
|
2024
Q1 | $2.5M | Sell |
16,300
-8,100
| -33% | -$1.21M | 0.01% | 688 |
|
|
2023
Q4 | $3.48M | Buy |
24,400
+6,900
| +39% | +$920K | 0.01% | 641 |
|
|
2023
Q3 | $2.29M | Buy |
17,500
+5,100
| +41% | +$775K | 0.01% | 682 |
|
|
2023
Q2 | $1.97M | Buy |
12,400
+2,900
| +31% | +$468K | 0.01% | 645 |
|
|
2023
Q1 | $1.5M | Sell |
9,500
-400
| -4% | -$60K | 0.01% | 665 |
|
|
2022
Q4 | $1.39M | Sell |
9,900
-7,900
| -44% | -$1.12M | 0.01% | 823 |
|
|
2022
Q3 | $2.29M | Buy |
17,800
+1,000
| +6% | +$144K | 0.01% | 708 |
|
|
2022
Q2 | $2.37M | Sell |
16,800
-54,000
| -76% | -$7.72M | 0.01% | 700 |
|
|
2022
Q1 | $9.84M | Sell |
70,800
-65,000
| -48% | -$9.96M | 0.03% | 468 |
|
|
2021
Q4 | $23.7M | Buy |
135,800
+11,700
| +9% | +$1.95M | 0.04% | 387 |
|
|
2021
Q3 | $20.6M | Buy |
124,100
+54,600
| +79% | +$9.4M | 0.04% | 417 |
|
|
2021
Q2 | $12.5M | Buy |
69,500
+18,900
| +37% | +$3.45M | 0.03% | 466 |
|
|
2021
Q1 | $9.76M | Buy |
50,600
+7,300
| +17% | +$1.41M | 0.03% | 468 |
|
|
2020
Q4 | $8.74M | Sell |
43,300
-5,200
| -11% | -$1.08M | 0.03% | 436 |
|
|
2020
Q3 | $10.2M | Buy |
48,500
+4,500
| +10% | +$1M | 0.05% | 318 |
|
|
2020
Q2 | $9.65M | Buy |
44,000
+23,700
| +117% | +$4.74M | 0.06% | 265 |
|
|
2020
Q1 | $3.52M | Sell |
20,300
-24,700
| -55% | -$4.08M | 0.06% | 366 |
|
|
2019
Q4 | $6.91M | Buy |
45,000
+10,100
| +29% | +$1.51M | 0.04% | 451 |
|
|
2019
Q3 | $5.3M | Buy |
34,900
+5,400
| +18% | +$854K | 0.04% | 417 |
|
|
2019
Q2 | $4.52M | Buy |
29,500
+12,800
| +77% | +$1.96M | 0.03% | 489 |
|
|
2019
Q1 | $2.68M | Buy |
16,700
+11,200
| +204% | +$1.74M | 0.02% | 506 |
|
|
2018
Q4 | $848K | Buy |
+5,500
| New | +$857K | 0.01% | 665 |
|
Other funds holding CLX
Capstone Investment Advisors's CLX Position: Q4 2024 in Review
Capstone Investment Advisors sold out of Clorox (CLX) in Q4 2024, closing a stake of 5,460 shares — an estimated $893K sold.
Capstone Investment Advisors first reported a position in CLX in Q3 2016 and held it in 20 quarters. The position peaked at $6.25M in Q3 2021. 1,225 funds tracked by Wall St. Rank hold CLX as of Q4 2024.
- Capstone Investment Advisors reported no remaining Clorox position as of Q4 2024 after selling out during the quarter.
- Capstone Investment Advisors sold 5,460 Clorox shares in Q4 2024, an estimated $893K.
- Capstone Investment Advisors first reported a position in Clorox in Q3 2016 and held it in 20 quarters.
- Capstone Investment Advisors's Clorox position peaked at $6.25M in Q3 2021.
- 1,225 funds tracked by Wall St. Rank held Clorox as of Q4 2024.
Based on Capstone Investment Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.